Chronic exogenous corticosterone administration generates an insulin-resistant brain state in rats

Stress

Volumn 13, Issue 2, 2010, Pages 123-131

  Osmanovic, Jelena ^a,b   Plaschke, Konstanze ^c   Salkovic Petrisic, Melita ^a   Grnblatt, Edna ^b   Riederer, Peter ^b   Hoyer, Siegfried ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Brain; Exogenous corticosterone; Gene expression; Insulin; Rat cognition

Indexed keywords

CORTICOSTERONE; ENZYME; INSULIN; INSULIN RECEPTOR; PLACEBO; SESAME SEED OIL; TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APTITUDE; ARTICLE; BEHAVIOR; BODY WEIGHT; BRAIN; BRAIN CORTEX; BRAIN TISSUE; COGNITION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOMETRY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; COGNITION DISORDERS; CORTICOSTERONE; GENE EXPRESSION; INSULIN; INSULIN RESISTANCE; INSULYSIN; MALE; MEMORY; RATS; RATS, WISTAR; RECEPTOR, INSULIN; STRESS, PSYCHOLOGICAL; TAU PROTEINS;

EID: 77949285848     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890903080379     Document Type: Article

References (57)

1. Blennow K, de Leon MJ, Zetterberg H. 2006. Alzheimer's disease: Seminar. Lancet 368:387-403.
2. Dai J, Buijs R, Swaab D. 2004. Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer's disease. Br J Pharmacol 143:606-610.
3. 2O or sham anaesthesia. Lab Anim 36:105-114.
4. De Kloet ER, Vreugdenhil E, Oitzl MS, Joëls M. 1998. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301.
5. De Kloet CS, Vermetten E, Geuze E, Kavelaars A, Heijnen CJ, Westenberg HG. 2006. Assessment of HPA-axis function in posttraumatic stress disorder: Pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res 40: 550-567.
6. De Leon MJ, McRae T, Tsai JR, George AE, Marcus DL, Freedman M, Wolf AP, McEwen B. 1988. Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet 2:391-392.
7. De Quervain DJ, Poirier R, Wollmer MA, Grimaldi LM, Tsolaki M, Streffer JR, Hock C, Nitsch RM, Mohajeri MH, Papassotir-opoulos A. 2004. Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet 13:47-52.
8. Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ. 1993. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 91:2020-2030. (Pubitemid 23141474)
9. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. 2006. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26: 9047-9056.
10. Grünblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S. 2007. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101:757-770.
11. Hart GW. 1997. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 66:315-335.
12. Haugher RL, Millan MA, Catt KJ, Aguilera G. 1987. Differential regulation of brain and pituitary corticotropin-releasing factor receptors by corticosterone. Endocrinology 120:1527-1533. (Pubitemid 17054010)
13. Holsboer F, Barden N. 1996. Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocr Rev 17:187-205.
14. Horner CH, O'Regan M, Arbuthnott E. 1991. Neural plasticity of the hippocampal (CA1) pyramidal cell-Quantitative changes in spine density following handling and injection for drug testing. J Anat 174:229-238.
15. Hoyer S. 2004. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490: 115-125.
16. Hoyer S, Froelich L. 2006. Brain insulin function and insulin signal transduction in sporadic Alzheimer disease, Chapter 11. In: Sun MK, editor. Research progress in Alzheimer's disease and dementia. New York, NY: Nova Science.
17. Hoyer S, Lannert H. 2008. Long-term effects of corticosterone on behavior, oxidative and energy metabolism of parietotemporal cerebral cortex and hippocampus. J Neural Transm 115: 1241-1249.
18. Karuri AR, Engelking LR, Kumar MS. 1998. Effects of halothane and methoxyflurane on the hypothalamic-pituitary-adrenal axis in rat. Brain Res Bull 47:205-209.
19. Kulstad JJ, McMillan PJ, Leverenz JB, Cook DG, Green PS, Peskind ER, Wilkinson CW, Farris W, Mehta PD, Craft S. 2005. Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque. J Neuropathol Exp Neurol 64:139-146.
20. Landfield PW, Blalock EM, Chen KC, Porter MM. 2007. A new glucocorticoid hypothesis of brain aging: Implications for Alzheimer's disease. Curr Alzheimer Res 4:205-212.
21. Lannert H, Hoyer S. 1998. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112:1199-1208. (Pubitemid 28519002)
22. Lupien SJ, Fiocco A, Wan N, Maheu F, Lord C, Schramek T, Tu MT. 2005. Stress hormones and human memory function across the lifespan. Psychneuroendocrinology 30:225-242.
23. Marklund N, Peltonen M, Nilsson TK, Olsson T. 2004. Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med 256:15-21.
24. McDowell I. 2001. Alzheimer's disease: Insights from epidemiology. Aging 13:143-162.
25. McEwen BS. 1999. Stress and hippocampal plasticity. Annu Rev Neurosci 22:105-122.
26. Meijer OC, de Kloet ER. 1998. Corticosterone and serotonergic neurotransmission in the hippocampus: Functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 12:1-20.
27. Melcangi RC, Panzica G. 2003. Steroids and the nervous system. Ann NY Acad Sci 1007:1-5.
28. Morimoto M, Morita N, Ozawa H, Yokoyama K, Kawata M. 1996. Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: An immunohistochemical and in situ hybridization study. Neurosci Res 26:235-269.
29. Murialdo G, Nobili F, Rollero A, Gianelli MV, Copello F, Rodriguez G, Polleri A. 2000. Hippocampal perfusion and pituitary-adrenal axis in Alzheimer's disease. Neuropsychobiol-ogy 42:51-57.
30. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME. 1994. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 14:2047-2053.
31. O'Brien JT, Ames D, Schweitzer I, Colman P, Desmond P, Tress B. 1996. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary- adrenal axis function in depression and Alzheimer's disease. Br J Psychiatry 168:679-687.
32. Park CR. 2001. Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 25:311-323.
33. Pérez A, Morelli L, Cresto JC, Castaño EM. 2000. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem Res 25:247-255.
34. Piroli GG, Grillo CA, Reznikov LR, Adams S, McEwen BS, Charron MJ, Reagan LP. 2007. Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinology 85:71-80.
35. Plaschke K, Hoyer S. 1993. Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 11: 477-483.
36. Plaschke K, Yun SW, Martin E, Hoyer S, Bardenheuer HJ. 1999. Interrelation between cerebral energy metabolism and behaviour in a rat model of permanent brain vessel occlusion. Brain Res 830:320-329.
37. Plaschke K, Feindt J, Djuric Z, Heiland S, Autschbach F, Lewicka S, Martin E, Bardenheuer HJ, Nawroth PP, Bierhaus A. 2006. Chronic corticosterone-induced deterioration in rat behaviour is not paralleled by changes in hippocampal NF-kappaB-activation. Stress 9:97-106.
38. Plotsky PM, Owens MJ, Nemeroff CB. 1998. Psychoneuroendo-crinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 21:293-307.
39. Roder HM, Ingram VM. 1991. Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios. J Neurosci 11:3325-3343.
40. Salkovic-Petrisic M, Hoyer S. 2007. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: An experimental approach. J Neural Transm Suppl 72:217-233.
41. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P. 2006. Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96:1005-1015.
42. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM. 2005. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 7:63-80.
43. Stein-Behrens B, Mattson MP, Chang I, Yeh M, Sapolsky R. 1994. Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J Neurosci 14:5373-5380.
44. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP. 2008. Diabetes impairs hippocampal function through glucocorticoid-mediated effect on new and mature neurons. Nat Neurosci 11:309-317.
45. Stratakis CA, Chrousos GP. 1995. Neuroendocrinology and pathophysiology of the stress system. Ann NYAcad Sci 771:1-18.
46. Svaren J, Ehrig T, Abdulkadir SA, Ehrengruber MU, Watson MA, Milbrandt J. 2000. EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem 275: 38524-38531.
47. van der Staay FJ, van NiesJ, RaaijmakersW.1990. The effectsofaging in rats on working and reference memory performance in a spatial holeboard discrimination task. Behav Neural Biol 53:356-370. (Pubitemid 20175796)
48. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESE-ARCH0034.
49. Vanitallie TB. 2002. Stress: A risk factor for serious illness. Metabolism 51:40-45.
50. Vecsei P. 1979. Glucocorticoids: Cortisol, cortisone, corticosterone, compound S, and their metabolites. In: Jaffe BM, Behrmann HR, editors. Methods of hormone radioimmunoassays. New York, NY: Academic Press. p 767-792.
51. Virgin CE, Jr, Ha TP, Packan DR, Tombaugh GC, Yang SH, Horner HC, Sapolsky RM. 1991. Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: Implications for glucocorticoid neurotoxicity. J Neurochem 57:1422-1428.
52. Vollmayr B, Faust H, Lewicka S, Henn FA. 2001. Brain-derived- neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness. Mol Psychiatry 6:471-474. (Pubitemid 32566101)
53. Weiland NG, Orikasa C, Hayashi S, McEwen BS. 1997. Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. J Comp Neurol 388:603-612.
54. Wolf OT. 2003. HPA axis and memory. Best Pract Res Clin Endocrinol Metab 17:287-299.
55. Woolley CS, Gould E, McEwen BS. 1990. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocam-pal pyramidal neurons. Brain Res 531:225-231.
56. Young AH, Sahakian BJ, Robbins TW, Cowen PJ. 1999. The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl) 145:260-266.
57. Zhao WQ, Chen H, Quon MJ, Alkon DL. 2004. Insulin and the insulin receptor in experimental models of learning and memory. Eur J Pharmacol 490:71-81.